Status:
COMPLETED
Immunometabolic Effects of Non-drug Strategies in the Clinical Management of Obesity: Translational Study
Lead Sponsor:
Fauqué
Collaborating Sponsors:
Institut Polyclinique de Cannes (IPOCA)
Conditions:
Obesity
Obesity, Abdominal
Eligibility:
FEMALE
18-75 years
Phase:
NA
Brief Summary
Forty women aged between 18 and 75 years-old with a BMI\> 30kg/m2 are recruited to participate in the evaluation of their medical management. They participate in an 8-week protocol as part of hospital...
Detailed Description
Obesity-related inflammation is central to the development of type 2 diabetes and potentiated by advancing age, inactive behavior and sedentary lifestyle. Metabolism and immunity are entangled in thei...
Eligibility Criteria
Inclusion
- BMI\> 30; aged between 18 and 75 years
Exclusion
- Pregnant and/or lactating women; not affiliated with social security; not mutual health insurance; person deprived of liberty; participation in clinical research in the last 6 months
- Non-inclusion criteria:
- HLA-DRB1\*04-03/06 polymorphisms; recent hospitalization (\<1 month); food supplement based on antioxidant; medicated in fibrate/telmisartan (modulator of PPARs)
Key Trial Info
Start Date :
July 2 2018
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
March 16 2020
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT04436419
Start Date
July 2 2018
End Date
March 16 2020
Last Update
June 24 2020
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Policlinic of Oxford (IPOCA)
Cannes, France, 06400